BR0114258A - Esteróides de 17alfa-fluoroalquila, processo para sua produção e composições farmacêuticas que contêm estes compostos - Google Patents

Esteróides de 17alfa-fluoroalquila, processo para sua produção e composições farmacêuticas que contêm estes compostos

Info

Publication number
BR0114258A
BR0114258A BR0114258-5A BR0114258A BR0114258A BR 0114258 A BR0114258 A BR 0114258A BR 0114258 A BR0114258 A BR 0114258A BR 0114258 A BR0114258 A BR 0114258A
Authority
BR
Brazil
Prior art keywords
compounds
compositions containing
steroids
pharmaceutical compositions
production process
Prior art date
Application number
BR0114258-5A
Other languages
English (en)
Inventor
Sven Ring
Guenter Kaufmann
Ralf Wyrwa
Walter Elger
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of BR0114258A publication Critical patent/BR0114258A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • C07J71/0047—Nitrogen only at position 2(3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0057—Nitrogen and oxygen
    • C07J71/0063—Nitrogen and oxygen at position 2(3)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0073—Sulfur-containing hetero ring
    • C07J71/0078—Sulfur-containing hetero ring containing only sulfur
    • C07J71/0084—Episulfides

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

"ESTERóIDES DE 17ALFA-FLUOROALQUILA, PROCESSO PARA SUA PRODUçãO E COMPOSIçõES FARMACêUTICAS QUE CONTêM ESTES COMPOSTOS". A presente invenção refere-se a esteróides de 17<244>-fluoroalquila de fórmula geral (I), em que R~ 3~ representa um grupo da fórmula CnFmHo, em que n = 1, 2, 3, 4, 5 ou 6, m > 1 e m + o = 2n + 1. A invenção também refere-se a métodos para produzir os mesmos e a composições que contêm os referidos compostos. A composição inventiva da fórmula geral (1) possui atividade androgênica.
BR0114258-5A 2000-09-29 2001-09-28 Esteróides de 17alfa-fluoroalquila, processo para sua produção e composições farmacêuticas que contêm estes compostos BR0114258A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10049736A DE10049736A1 (de) 2000-09-29 2000-09-29 17alpha-Fluoralkylsteroide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
PCT/DE2001/003732 WO2002026759A2 (de) 2000-09-29 2001-09-28 17α-FLUORALKYLSTEROIDE, VERFAHREN ZU DEREN HERSTELLUNG UND DIESE VERBINDUNGEN ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN

Publications (1)

Publication Number Publication Date
BR0114258A true BR0114258A (pt) 2003-12-30

Family

ID=7659018

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0114258-5A BR0114258A (pt) 2000-09-29 2001-09-28 Esteróides de 17alfa-fluoroalquila, processo para sua produção e composições farmacêuticas que contêm estes compostos

Country Status (29)

Country Link
US (1) US20040024231A1 (pt)
EP (1) EP1322660B1 (pt)
JP (1) JP2004509971A (pt)
KR (1) KR20030061815A (pt)
CN (1) CN1305890C (pt)
AT (1) ATE338054T1 (pt)
AU (1) AU1382202A (pt)
BG (1) BG107763A (pt)
BR (1) BR0114258A (pt)
CA (1) CA2422056A1 (pt)
DE (2) DE10049736A1 (pt)
DK (1) DK1322660T3 (pt)
EA (1) EA005772B1 (pt)
EE (1) EE200300124A (pt)
ES (1) ES2272550T3 (pt)
HK (1) HK1061860A1 (pt)
HR (1) HRP20030334A2 (pt)
HU (1) HUP0301198A2 (pt)
IL (2) IL154828A0 (pt)
MX (1) MXPA03002606A (pt)
NO (1) NO325058B1 (pt)
NZ (1) NZ524781A (pt)
PL (1) PL361666A1 (pt)
PT (1) PT1322660E (pt)
SK (1) SK5192003A3 (pt)
UA (1) UA76125C2 (pt)
WO (1) WO2002026759A2 (pt)
YU (1) YU22903A (pt)
ZA (1) ZA200303216B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
US20050182322A1 (en) * 2004-02-17 2005-08-18 Liebel-Flarsheim Company Injector auto purge
EP1854465A1 (en) * 2006-05-12 2007-11-14 Alexander Tobias Teichmann Use of 4,17 beta-dihydroxyandrost-4-ene-3-one for treating cancers
DE102006054535A1 (de) * 2006-11-15 2008-05-21 Bayer Schering Pharma Aktiengesellschaft Progesteronrezeptorantagonisten
KR101044794B1 (ko) * 2011-01-05 2011-06-27 연규백 복합판넬에 브이 홈을 컷팅하는 장치
CN102964411B (zh) * 2012-12-03 2015-04-22 华中药业股份有限公司 一种雄甾-4,6-二烯-17α-甲基-17β-醇-3-酮的合成方法
CN114409717B (zh) * 2021-12-17 2023-03-17 湖南科益新生物医药有限公司 替勃龙中间体醚化物和替勃龙的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3029261A (en) * 1959-11-30 1962-04-10 Syntex Sa Steroidal fluoro compounds and process for the production thereof
US3046273A (en) * 1961-01-18 1962-07-24 Merck & Co Inc Novel 17alpha-trifluoro-propynyl androstenes and processes
US3255182A (en) * 1961-02-13 1966-06-07 Merck & Co Inc 17alpha-haloethynyl-[3, 2-c]pyrazolo androstenes and intermediates therefor
CH431508A (de) * 1961-06-16 1967-03-15 Ciba Geigy Verfahren zur Ketalisierung der 3-Oxogruppe in 5(10)-3-Oxo-19-nor-steroiden
US3098851A (en) * 1961-11-20 1963-07-23 Searle & Co 17alpha-alkynyl-2beta-halo-5alpha-androstane-3alpha, 17beta-diols, esters thereof, and intermediates thereto
US3092623A (en) * 1961-12-01 1963-06-04 Merck & Co Inc [3, 2-c] pyrazolo-4, 9-androstadienes
US3076825A (en) * 1962-02-14 1963-02-05 Syntex Corp 17alpha-(1'-fluoroethyl) and 17alpha-(1', 1'-difluoroethyl) androstane derivatives and process therefor
US3340251A (en) * 1965-10-18 1967-09-05 Merck & Co Inc 17beta-hydroxy-17alpha-halohydrocarbon-19-nor-androst-4-ene-3-ones and the delta5(10)-isomers thereof
WO1993013122A1 (de) * 1991-12-22 1993-07-08 Schering Aktiengesellschaft 3-methylsulfonylhydrazono- und 3-oxyimino-steroide, ein verfahren zu deren herstellung, diese steroide enthaltende pharmazeutische präparate sowie ihre verwendung zur herstellung von arzneimitteln
CN1072678C (zh) * 1994-05-30 2001-10-10 中国科学院上海有机化学研究所 三氟甲基甾体化合物、制备及其用途
DE19706061A1 (de) * 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
DE19860719A1 (de) * 1998-12-23 2000-06-29 Schering Ag Neue Testosteronderivate und ihre Verwendung zur Langzeittherapie von Androgen-abhängigen Erkrankungen
DE10221034A1 (de) * 2002-05-03 2003-11-20 Schering Ag 17alpha-Fluoralkyl-11ß-benzaldoxim-Steroide, Verfahren zu deren Herstellung, diese Steroide enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln

Also Published As

Publication number Publication date
ES2272550T3 (es) 2007-05-01
IL154828A0 (en) 2003-10-31
NO325058B1 (no) 2008-01-21
JP2004509971A (ja) 2004-04-02
CN1466592A (zh) 2004-01-07
BG107763A (bg) 2004-03-31
WO2002026759A2 (de) 2002-04-04
EA005772B1 (ru) 2005-06-30
HK1061860A1 (en) 2004-10-08
HRP20030334A2 (en) 2005-06-30
EP1322660B1 (de) 2006-08-30
NO20031444L (no) 2003-05-28
AU1382202A (en) 2002-04-08
UA76125C2 (en) 2006-07-17
KR20030061815A (ko) 2003-07-22
DK1322660T3 (da) 2007-01-08
ZA200303216B (en) 2005-02-03
SK5192003A3 (en) 2003-09-11
DE10049736A1 (de) 2002-04-18
MXPA03002606A (es) 2003-06-30
EP1322660A2 (de) 2003-07-02
CA2422056A1 (en) 2003-03-11
IL154828A (en) 2007-07-24
CN1305890C (zh) 2007-03-21
US20040024231A1 (en) 2004-02-05
NO20031444D0 (no) 2003-03-28
NZ524781A (en) 2004-09-24
HUP0301198A2 (hu) 2003-09-29
WO2002026759A3 (de) 2002-06-20
PT1322660E (pt) 2007-01-31
EA200300400A1 (ru) 2003-10-30
DE50110892D1 (de) 2006-10-12
EE200300124A (et) 2005-04-15
ATE338054T1 (de) 2006-09-15
YU22903A (sh) 2006-03-03
PL361666A1 (en) 2004-10-04

Similar Documents

Publication Publication Date Title
BR0108871A (pt) Composto, processo de preparação de compostos, e, composição farmacêutica
BR0212185A (pt) Compostos e métodos para a preparação de compostos
BR9911783A (pt) Compostos cìclicos substituìdos, processo para sua preparação e composições farmacêuticas que os contêm
BR9811533A (pt) Produção de compostos avermectina
BR0010555A (pt) Inibidores de neuraminidases
YU56995A (sh) Soli derivata indola
BR0210464A (pt) Composto, composição farmacêutica, processo para preparar um composto, e, uso de um composto
BR0314379A (pt) Quinazolinonas espirocondensadas e a sua utilização como inibidores de fosfodiesterase
BR9808953A (pt) Composto, processo para tratar um distúrbio mediado pela ciclooxigenase-2 em um paciente, e, composição farmacêutica
BR9916633A (pt) Benzopiranos e benzoxepinas, composições farmacêuticas compreendendo-as e processo de preparação
BR0011738A (pt) Derivados de benzeno, processo para a preparação dos mesmos e composições farmacêuticas que os contêm
BR0214142A (pt) Derivados e intermediários de n-adamantilmetila como composições farmacêuticas e processos para sua preparação
DOP2002000512A (es) Sales de acido succinato de 5,7,14-triazatetraciclo [10.3.1.0² ¹¹.04,9] hexadeca-2 (11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas
BR9913589A (pt) Composição, e, processo cosmético para reduzir ardência ou irritação induzidas pela aplicação tópica de uma composição
BRPI0208468B8 (pt) camsilato de amlodipina e processo para sua preparação
BR9805031A (pt) Compostos de naftaleno, processo para sua preparação e composições farmacêuticas contendo os mesmos.
BR0311410A (pt) Composto de piperidina
BR0114258A (pt) Esteróides de 17alfa-fluoroalquila, processo para sua produção e composições farmacêuticas que contêm estes compostos
BR9813217A (pt) Tetraciclos, processo para a produção dos mesmos e preparações farmacêuticas contendo estes compostos
BR9807988A (pt) Processo para a preparação de um composto, e, composto.
BR9911250A (pt) Processo para preparação de compostos
BR9912870A (pt) Processo para sìntese de derivados de (1h) - benzo (c)quinolizina-3-onas
BR9801448A (pt) Compostos heterocìclicos, processo para sua preparação e composições farmacêuticas contendo os mesmos.
AU2002218422A1 (en) New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof
BR0108840A (pt) Composto, prodroga, processo para produzir um composto, composição farmacêutica, método para prevenir ou tratar doenças inflamatórias, e, uso de um composto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A , 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2112 DE 28/06/2011.